Browsing: statins

In a significant development, Novartis has launched a cutting-edge therapy designed to lower bad cholesterol levels, providing hope for patients at high risk of cardiovascular issues. This innovative treatment has the potential to dramatically improve the lives of those dealing with high cholesterol, a key risk factor for heart disease and stroke.

A study by SingHealth Polyclinics (SHP) has found that medication adherence is the most critical factor in lowering cholesterol levels. Adherence to medication can be up to 85% effective, while changes to diet and exercise can only lower levels by 10-20%.